Monoclonal antibody A7 coupled to magnetic particles as a contrast enhancing agent for magnetic resonance imaging of human colorectal carcinoma

Cancer Immunology, Immunotherapy

Volumn 55, Issue 6, 2006, Pages 728-733

  Otsuji, Eigo ^a   Kuriu, Yoshiaki ^a   Okamoto, Kazuma ^a   Ichikawa, Daisuke ^a   Hagiwara, Akeo ^a   Ito, Hirotoshi ^a   Nishimura, Tsunehiko ^a   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Contrast agent; Ferromagnetic particles; Magnetic resonance imaging; Monoclonal antibody

Indexed keywords

FERROMAGNETIC MATERIAL; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A7; MONOCLONAL ANTIBODY A7 I 25; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BIOACCUMULATION; CANCER DIAGNOSIS; CANCER GRAFT; COLORECTAL CARCINOMA; COMPLEX FORMATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TISSUE LEVEL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INJECTION; ISOTOPE LABELING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PRIORITY JOURNAL; RECTUM CARCINOMA; TUMOR XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FERRIC COMPOUNDS; HUMANS; IMMUNOCONJUGATES; IODINE RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL;

EID: 33644592204     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-005-0067-9     Document Type: Article

References (24)

1. Ballou B, Levine G, Hakala TR, Solter D (1979) Tumor location detected with radioactively labeled monoclonal antibody and external scintigraphy. Science 206:844-847
2. Borris TJ, Weber CR (1999) Ferromagnetic MRI artifact secondary to a previous mandibular modified condylotomy. Br J Oral Maxillofac Surg 37:104-105
3. 131I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study. Nucl Med Commun 23:229-236
4. Bydder GM (1987) Clinical application of gadolinium-DTPA. In: Stark DD, Bradley WG (eds) Magnetic resonance imaging. Mosby, St Louis, pp 182-200
5. Condon B, Hadley DM, Hodgson R (2001) The ferromagnetic pillow: a potential MR hazard not detectable by a hand-held magnet. Br J Radiol 74:847-851
6. Del Sole A, Moncayo R, Tafuni G, Lucignani G (2004) Position of nuclear medicine techniques in the diagnostic work-up of brain tumors. Q J Nucl Med Mol Imaging. 48:76-81
7. Di Matteo G, Peparini N, Maturo A, Di Matteo FM, Zeri KP, Redler A, Mascagni D (2001) Lateral pelvic lymphadenectomy and total nerve sparing for locally advanced rectal cancer in Western patients. Panminerva Med 43:95-101
8. 131I-labelled human growth hormone of high specific activity. Nature 194:495-496
9. Jani AB, Blend MJ, Hamilton R, Brendler C, Pelizzari C, Krauz L, Sapra B, Vijayakumar S, Awan A, Weichselbaum RR (2004) Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control. J Nucl Med 45:1315-1322
10. Kitamura K, Takahashi T, Yamaguchi T, Yokota T, Noguchi A, Amagai T, Imanishi J (1989) Immunochemical characterization of the antigen recognized by the murine monoclonal antibody A7 against human colorectal cancer. Tohoku J Exp Med. 157:83-93
11. Mendonca-Diasand MH, Lauterbur PC (1986) Biological trace elements research. Magn Reson Med 3: 328-330
12. Molday RS, Yen SPS, Rembaum A (1977) Application of magnetic microspheres in labelling and separation of cells. Nature 268:437-438
13. Nakada K, Sakamoto J, Watanabe T, Itoh K, Akiyama S, Takagi H (1997) Imaging of recurrent intestinal carcinoma with indium-111-labeled anti-carcinoembrionic antigen CEA102. Jpn J Cancer Res 88:605-613
14. Oriuchi N, Watanabe N, Sugimachi S, Higuchi T, Imai K, Yamanaka H, Hashimoto M, Kanda H, Endo K (1996) Different biodistribution of 99mTc-labelled chimeric mouse-human monoclonal antibody between athymic mice model and human. Br J Cancer 73:1466-1472
15. Otsuji E, Yamaguchi Y, Yamaguchi N, Koyama K, Imanishi J, Yamaoka N, Takahashi T (1992) Expression of the cell surface antigen detected by the monoclonal antibody A7 in pancreatic carcinoma cell lines. Jpn J Surg 22:351-356
16. Otsuji E, Tsuruta H, Toma A, Kobayashi S, Okamoto K, Yata Y, Yamagishi H (2003) Effects of idiotypic human anti-mouse antibody against in vitro binding and antitumor activity of a monoclonal antibody-drug conjugate. Hepato Gasroenterol 50:380-384
17. Phom H, Kumar A, Tripathi M, Chandrashekar N, Choudhry VP, Malhotra A, Bal CS (2004) Comparative evaluation of Tc-99 m-heat-denatured RBC and Tc-99 m-anti-D IgG opsonized RBC spleen planar and SPECT scintigraphy in the detection of accessory spleen in post splenectomy patients with chronic idiopathic thrombocytopenic purpura. Clin Nucl Med 29:403-409
18. Renshaw PF, Owen CS, McLaughlin AC, Frey TG, Leigh JS (1986) Ferromagnetic contrast agents: a new approach. Magn Reson Med 3:217-225
19. Saini S, Stark DD, Hahn PF, Bousquet JC, Introcasso J, Wittenberg J, Brady TJ, Ferrucci JT (1987) Ferrite particles: A superparamagnetic MR contrast agent for enhanced detection of liver carcinoma. Radiology 162:217-222
20. Schoefl GI (1963) Studies on inflammation. III. Growing capillaries: their structure and permeability. Viwchow's Arch Path Anat 337:97-141
21. Seneterre E, Weissleder R, Jaramillo D, Reimer P, Lee AS, Brady TJ, Wittenberg J (1991) Bone marrow: Ultrasmall superparamagnetic iron oxide for MR imaging. Radiology 179:529-533
22. Stark DD, Weissleder R, Elizondo G, Hahn PF, Saini S, Todd LE, Wittenberg J, Ferrucci JT (1988) Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 168:297-301
23. Takahashi T, Yamaguchi T, Kitamura K, Noguchi A, Honda M, Otsuji E (1993) Follow-up study of patients treated with monoclonal antibody-drug conjugate: report of 77 cases with colorectal cancer. Jpn J Cancer Res 84:976-981
24. Weissleder R, Elizondo G, Wittenberg J, Rabiato CA, Bebgele HH, Josephson L (1990) Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175:494-498